Profile data is unavailable for this security.
About the company
Telomir Pharmaceuticals, Inc. is a United States-based company. The Company operates as pre-clinical-stage pharmaceutical company focused on developing TELOMIR-1 small molecule to lengthen the deoxyribonucleic acid’s (DNA) protective telomere caps to affect age reversal. It selectively affects the processes that drive the concentration and accumulation of iron and copper in the serum that affects diseases like hemochromatosis and cancer.
- Revenue in USD (TTM)0.00
- Net income in USD-22.96m
- Incorporated2021
- Employees1.00
- LocationTelomir Pharmaceuticals Inc900 West Platt Street, Suite 200TAMPA 33606United StatesUSA
- Phone+1 (813) 864-2562
- Websitehttps://telomirpharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rockwell Medical Inc | 98.92m | -1.24m | 71.10m | 237.00 | -- | 2.44 | 49.86 | 0.7188 | -0.0496 | -0.0496 | 3.23 | 0.9015 | 1.80 | 14.45 | 10.84 | 417,371.30 | -2.25 | -46.29 | -3.34 | -65.38 | 16.91 | 4.66 | -1.25 | -36.51 | 2.00 | 0.3194 | 0.2654 | -- | 14.84 | 5.69 | 54.82 | -- | 76.21 | -- |
| Journey Medical Corp | 57.77m | -18.34m | 77.43m | 58.00 | -- | 9.87 | -- | 1.34 | -0.9276 | -0.9276 | 2.93 | 0.5271 | 0.889 | 2.16 | 6.19 | 996,051.80 | -28.22 | -- | -76.21 | -- | 57.32 | -- | -31.74 | -- | 1.03 | -13.65 | 0.6582 | -- | 7.48 | -- | 87.00 | -- | -- | -- |
| I-Mab ADR | -100.00bn | -100.00bn | 77.57m | 220.00 | -- | 0.33 | -- | -- | -- | -- | -- | 2.91 | -- | -- | -- | -- | -- | -35.51 | -- | -41.43 | -- | -- | -- | -509.54 | -- | -- | 0.00 | -- | 111.86 | -13.65 | 44.45 | -- | -5.95 | -- |
| Zhong Yuan Bio-Technology Holdings Ltd | 2.49m | 232.02k | 88.37m | 35.00 | 391.37 | 348.44 | -- | 35.44 | 0.0128 | -0.0176 | 0.1395 | 0.0143 | 0.8583 | -1.61 | 3.25 | 71,253.43 | 6.49 | -- | 19.10 | -- | 106.30 | -- | 7.57 | -- | 0.8309 | 2.53 | 0.8593 | -- | -28.60 | -- | -148.37 | -- | -- | -- |
| Assertio Holdings Inc | 125.76m | -68.49m | 92.07m | 53.00 | -- | 0.7056 | -- | 0.7321 | -0.7212 | -0.7212 | 1.32 | 1.37 | 0.3834 | 0.9052 | 2.34 | 2,372,887.00 | -20.88 | -21.51 | -30.33 | -32.05 | 70.31 | 88.68 | -54.46 | -62.10 | 1.57 | -- | 0.2293 | -- | -2.67 | -13.38 | -402.80 | -- | -28.25 | -- |
| Scilex Holding Co | 50.83m | -171.53m | 105.77m | 113.00 | -- | -- | -- | 2.08 | -1.40 | -1.40 | 0.4425 | -1.77 | 0.4401 | 5.22 | 1.55 | 484,123.80 | -102.93 | -- | -- | -- | 68.24 | -- | -233.88 | -- | 0.1853 | -3.72 | -- | -- | 22.90 | -- | -614.67 | -- | -- | -- |
| Procaps Group SA | 414.10m | 52.20m | 125.23m | 5.50k | 2.13 | 3.18 | 1.80 | 0.3024 | 0.5209 | 0.5209 | 4.16 | 0.3491 | 0.854 | 1.87 | 3.38 | 75,290.18 | 10.77 | -- | 19.01 | -- | 55.04 | -- | 12.61 | -- | 0.9861 | -- | 0.8829 | -- | 0.0434 | -- | 142.18 | -- | -- | -- |
| Telomir Pharmaceuticals Inc | 0.00 | -22.96m | 132.36m | 1.00 | -- | 299.40 | -- | -- | -0.8145 | -0.8145 | 0.00 | 0.0149 | 0.00 | -- | -- | 0.00 | -721.99 | -- | -1,752.70 | -- | -- | -- | -- | -- | -- | -2.06 | 0.00 | -- | -- | -- | -1,430.39 | -- | -- | -- |
| Puma Biotechnology Inc | 243.57m | 23.24m | 142.35m | 185.00 | 6.11 | 2.00 | 4.09 | 0.5845 | 0.475 | 0.475 | 5.03 | 1.45 | 1.15 | 17.91 | 5.83 | 1,316,589.00 | 10.95 | -12.21 | 18.85 | -20.53 | 69.29 | 78.78 | 9.54 | -11.79 | 1.40 | 3.61 | 0.5234 | -- | 3.34 | -1.25 | 1,079,450.00 | -- | 83.41 | -- |
| Elutia Inc | 24.78m | -60.29m | 152.07m | 54.00 | -- | -- | -- | 6.14 | -2.10 | -1.84 | 0.8695 | -1.16 | 0.4813 | 2.82 | 8.52 | 458,925.90 | -117.08 | -42.93 | -649.22 | -79.34 | 42.41 | 43.32 | -243.28 | -64.16 | 0.849 | -1.18 | -- | -- | -49.69 | -8.71 | -25.39 | -- | 12.74 | -- |
| LifeVantage Corp | 196.01m | 4.13m | 164.83m | 217.00 | 41.23 | 5.93 | 21.71 | 0.8409 | 0.3192 | 0.3192 | 15.27 | 2.22 | 3.06 | 2.50 | 71.64 | 903,290.30 | 6.46 | 9.95 | 10.17 | 15.55 | 79.21 | 81.45 | 2.11 | 3.08 | 0.9923 | 559.36 | 0.00 | 26.95 | -6.20 | -2.40 | 15.63 | -16.94 | -2.18 | -- |
| Scpharmaceuticals Inc | 30.28m | -80.12m | 173.10m | 135.00 | -- | 5.64 | -- | 5.72 | -1.91 | -1.91 | 0.7417 | 0.6137 | 0.262 | 0.7268 | 4.52 | 224,281.50 | -69.31 | -38.23 | -78.18 | -42.31 | 69.72 | -- | -264.60 | -1,360.16 | 6.89 | -8.42 | 0.6246 | -- | -- | -- | -48.79 | -- | -- | -- |
| Mediwound Ltd | 20.14m | -19.97m | 180.78m | 100.00 | -- | 8.71 | -- | 8.98 | -2.16 | -2.16 | 2.18 | 1.92 | 0.3311 | 5.53 | 6.55 | 201,410.00 | -32.83 | -24.48 | -49.28 | -32.92 | 13.25 | 43.27 | -99.17 | -38.43 | 1.51 | -3.26 | 0.2623 | -- | -29.48 | 40.60 | 65.73 | -- | 64.66 | -- |
Data as of Nov 22 2024. Currency figures normalised to Telomir Pharmaceuticals Inc's reporting currency: US Dollar USD
6.61%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Sep 2024 | 1.14m | 3.85% |
| BlackRock Fund Advisorsas of 30 Sep 2024 | 355.64k | 1.20% |
| Geode Capital Management LLCas of 30 Sep 2024 | 238.74k | 0.81% |
| Suncoast Equity Management LLCas of 30 Sep 2024 | 51.19k | 0.17% |
| The Bank of New York Mellon Corp. (Investment Management)as of 30 Sep 2024 | 50.78k | 0.17% |
| Northern Trust Investments, Inc.(Investment Management)as of 30 Sep 2024 | 48.68k | 0.16% |
| SSgA Funds Management, Inc.as of 30 Sep 2024 | 36.09k | 0.12% |
| Beaird Harris Wealth Management LLCas of 30 Jun 2024 | 14.62k | 0.05% |
| New York State Common Retirement Fundas of 30 Sep 2024 | 11.80k | 0.04% |
| Charles Schwab Investment Management, Inc.as of 30 Sep 2024 | 10.85k | 0.04% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
